Leymus Genomics ApS
CVR number: 38106872
Hørkær 1 A, 2730 Herlev
rb@leymusgenomics.com
tel: 29722692
www.leymusgenomics.com
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 157.00 | 604.00 | 6 082.00 | 332.00 | -1 341.46 |
| Employee benefit expenses | -84.00 | - 118.00 | -2 574.00 | -1 959.00 | - 255.88 |
| Total depreciation | -34.00 | -36.00 | -38.00 | -18.00 | -54.56 |
| EBIT | - 275.00 | 450.00 | 3 470.00 | -1 645.00 | -1 651.90 |
| Other financial income | 1.00 | 100.00 | 24.00 | 32.00 | 27.52 |
| Other financial expenses | -96.00 | - 203.00 | -17.00 | -41.00 | -1.16 |
| Pre-tax profit | - 370.00 | 347.00 | 3 477.00 | -1 654.00 | -1 625.54 |
| Income taxes | - 433.00 | -2.00 | 356.52 | ||
| Net earnings | - 370.00 | 347.00 | 3 044.00 | -1 656.00 | -1 269.02 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 11.00 | 33.00 | 23.00 | 46.00 | |
| Machinery and equipment | 58.00 | 28.00 | 24.00 | 15.00 | 7.33 |
| Tangible assets total | 69.00 | 61.00 | 47.00 | 61.00 | 7.33 |
| Other receivables | 51.00 | 10.00 | 29.00 | 30.00 | |
| Investments total | 51.00 | 10.00 | 29.00 | 30.00 | |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 29.00 | 748.00 | 691.00 | 68.00 | |
| Current amounts owed by group member comp. | 75.00 | 1 237.00 | 375.00 | 761.28 | |
| Current other receivables | 27.00 | 11.00 | 22.00 | 197.00 | |
| Short term receivables total | 56.00 | 834.00 | 1 950.00 | 640.00 | 761.28 |
| Cash and bank deposits | 214.00 | 54.00 | 3 543.00 | 546.00 | 59.83 |
| Cash and cash equivalents | 214.00 | 54.00 | 3 543.00 | 546.00 | 59.83 |
| Balance sheet total (assets) | 390.00 | 959.00 | 5 569.00 | 1 277.00 | 828.45 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 625.00 | 625.00 | 625.00 | 625.00 | 625.00 |
| Shares repurchased | 882.00 | ||||
| Retained earnings | 36.00 | - 334.00 | - 869.00 | 2 175.00 | 519.46 |
| Profit of the financial year | - 370.00 | 347.00 | 3 044.00 | -1 656.00 | -1 269.02 |
| Shareholders equity total | 291.00 | 638.00 | 3 682.00 | 1 144.00 | - 124.55 |
| Provisions | 1.00 | 3.00 | |||
| Non-current liabilities total | |||||
| Current trade creditors | 17.00 | 15.00 | 41.00 | 25.00 | 866.91 |
| Short-term deferred tax liabilities | 432.00 | ||||
| Other non-interest bearing current liabilities | 82.00 | 306.00 | 1 413.00 | 105.00 | 86.09 |
| Current liabilities total | 99.00 | 321.00 | 1 886.00 | 130.00 | 953.00 |
| Balance sheet total (liabilities) | 390.00 | 959.00 | 5 569.00 | 1 277.00 | 828.45 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.